Sign in
4

Changes in Ownership

ORASURE TECHNOLOGIES INC Filed Acc 0001209784-18-000012

EVP & BU Lead - Molecular sold 20,000 shares at an average $17.97 ($359,460)

  • EVP & BU Lead - Molecular acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

SMITH BRIAN · EVP & BU Lead - Molecular

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2018-02-15 Exercise or conversion : show line 1 in the form +10,000 $5.96 $59,590 28,075 D
2018-02-15 Sale : show line 2 in the form −10,000 $17.95 $179,450 18,075 D
2018-02-16 Exercise or conversion : show line 3 in the form +10,000 $5.96 $59,590 28,075 D
2018-02-16 Sale : show line 4 in the form −10,000 $18.00 $180,010 18,075 D
Open-market sales · 20,000 sh · avg $17.97 · $359,460

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-02-15 Exercise or conversion : show line 5 in the form Nonqualified stock options −10,000 $5.96 2023-12-20 10,000 10,000 D
2018-02-16 Exercise or conversion : show line 6 in the form Nonqualified stock options −10,000 $5.96 2023-12-20 10,000 0 D
Loading xslF345X03/edgar.xml…